nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—CYP3A4—Thiotepa—urinary bladder cancer	0.209	0.687	CbGbCtD
Tinidazole—CYP3A4—Etoposide—urinary bladder cancer	0.0568	0.186	CbGbCtD
Tinidazole—CYP3A4—Doxorubicin—urinary bladder cancer	0.0387	0.127	CbGbCtD
Tinidazole—Decreased appetite—Fluorouracil—urinary bladder cancer	0.0011	0.00158	CcSEcCtD
Tinidazole—Asthenia—Thiotepa—urinary bladder cancer	0.0011	0.00158	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00109	0.00157	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00109	0.00157	CcSEcCtD
Tinidazole—Ataxia—Doxorubicin—urinary bladder cancer	0.00109	0.00157	CcSEcCtD
Tinidazole—Dysuria—Methotrexate—urinary bladder cancer	0.00108	0.00156	CcSEcCtD
Tinidazole—Neutropenia—Methotrexate—urinary bladder cancer	0.00108	0.00156	CcSEcCtD
Tinidazole—Pruritus—Thiotepa—urinary bladder cancer	0.00108	0.00156	CcSEcCtD
Tinidazole—Paraesthesia—Cisplatin—urinary bladder cancer	0.00108	0.00155	CcSEcCtD
Tinidazole—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00108	0.00155	CcSEcCtD
Tinidazole—Dyspnoea—Cisplatin—urinary bladder cancer	0.00107	0.00154	CcSEcCtD
Tinidazole—Skin disorder—Etoposide—urinary bladder cancer	0.00107	0.00154	CcSEcCtD
Tinidazole—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00106	0.00153	CcSEcCtD
Tinidazole—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00106	0.00153	CcSEcCtD
Tinidazole—Anorexia—Etoposide—urinary bladder cancer	0.00105	0.00151	CcSEcCtD
Tinidazole—Diarrhoea—Thiotepa—urinary bladder cancer	0.00105	0.00151	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00105	0.0015	CcSEcCtD
Tinidazole—Decreased appetite—Cisplatin—urinary bladder cancer	0.00104	0.0015	CcSEcCtD
Tinidazole—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00104	0.0015	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00104	0.00149	CcSEcCtD
Tinidazole—Drowsiness—Methotrexate—urinary bladder cancer	0.00103	0.00149	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00102	0.00147	CcSEcCtD
Tinidazole—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00102	0.00147	CcSEcCtD
Tinidazole—Dysuria—Epirubicin—urinary bladder cancer	0.00101	0.00146	CcSEcCtD
Tinidazole—Neutropenia—Epirubicin—urinary bladder cancer	0.00101	0.00146	CcSEcCtD
Tinidazole—Dizziness—Thiotepa—urinary bladder cancer	0.00101	0.00146	CcSEcCtD
Tinidazole—Stomatitis—Methotrexate—urinary bladder cancer	0.00101	0.00145	CcSEcCtD
Tinidazole—Urticaria—Fluorouracil—urinary bladder cancer	0.00101	0.00145	CcSEcCtD
Tinidazole—Body temperature increased—Fluorouracil—urinary bladder cancer	0.001	0.00144	CcSEcCtD
Tinidazole—Sweating—Methotrexate—urinary bladder cancer	0.00099	0.00143	CcSEcCtD
Tinidazole—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000989	0.00142	CcSEcCtD
Tinidazole—Paraesthesia—Etoposide—urinary bladder cancer	0.000988	0.00142	CcSEcCtD
Tinidazole—Dyspnoea—Etoposide—urinary bladder cancer	0.000981	0.00141	CcSEcCtD
Tinidazole—Somnolence—Etoposide—urinary bladder cancer	0.000978	0.00141	CcSEcCtD
Tinidazole—Vomiting—Thiotepa—urinary bladder cancer	0.000974	0.0014	CcSEcCtD
Tinidazole—Drowsiness—Epirubicin—urinary bladder cancer	0.000967	0.00139	CcSEcCtD
Tinidazole—Rash—Thiotepa—urinary bladder cancer	0.000965	0.00139	CcSEcCtD
Tinidazole—Dermatitis—Thiotepa—urinary bladder cancer	0.000965	0.00139	CcSEcCtD
Tinidazole—Headache—Thiotepa—urinary bladder cancer	0.000959	0.00138	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000958	0.00138	CcSEcCtD
Tinidazole—Decreased appetite—Etoposide—urinary bladder cancer	0.000956	0.00138	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00095	0.00137	CcSEcCtD
Tinidazole—Body temperature increased—Cisplatin—urinary bladder cancer	0.000949	0.00137	CcSEcCtD
Tinidazole—Fatigue—Etoposide—urinary bladder cancer	0.000948	0.00136	CcSEcCtD
Tinidazole—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000948	0.00136	CcSEcCtD
Tinidazole—Stomatitis—Epirubicin—urinary bladder cancer	0.000942	0.00136	CcSEcCtD
Tinidazole—Constipation—Etoposide—urinary bladder cancer	0.000941	0.00135	CcSEcCtD
Tinidazole—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00094	0.00135	CcSEcCtD
Tinidazole—Dysuria—Doxorubicin—urinary bladder cancer	0.000938	0.00135	CcSEcCtD
Tinidazole—Neutropenia—Doxorubicin—urinary bladder cancer	0.000938	0.00135	CcSEcCtD
Tinidazole—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000933	0.00134	CcSEcCtD
Tinidazole—Sweating—Epirubicin—urinary bladder cancer	0.000927	0.00133	CcSEcCtD
Tinidazole—Asthenia—Gemcitabine—urinary bladder cancer	0.000924	0.00133	CcSEcCtD
Tinidazole—Pharyngitis—Methotrexate—urinary bladder cancer	0.00092	0.00132	CcSEcCtD
Tinidazole—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000916	0.00132	CcSEcCtD
Tinidazole—Pruritus—Gemcitabine—urinary bladder cancer	0.000911	0.00131	CcSEcCtD
Tinidazole—Nausea—Thiotepa—urinary bladder cancer	0.000909	0.00131	CcSEcCtD
Tinidazole—Urethral disorder—Methotrexate—urinary bladder cancer	0.000909	0.00131	CcSEcCtD
Tinidazole—Feeling abnormal—Etoposide—urinary bladder cancer	0.000906	0.0013	CcSEcCtD
Tinidazole—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000899	0.00129	CcSEcCtD
Tinidazole—Pruritus—Fluorouracil—urinary bladder cancer	0.000896	0.00129	CcSEcCtD
Tinidazole—Drowsiness—Doxorubicin—urinary bladder cancer	0.000894	0.00129	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000887	0.00128	CcSEcCtD
Tinidazole—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000885	0.00127	CcSEcCtD
Tinidazole—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000881	0.00127	CcSEcCtD
Tinidazole—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000877	0.00126	CcSEcCtD
Tinidazole—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000877	0.00126	CcSEcCtD
Tinidazole—Urticaria—Etoposide—urinary bladder cancer	0.000874	0.00126	CcSEcCtD
Tinidazole—Stomatitis—Doxorubicin—urinary bladder cancer	0.000872	0.00125	CcSEcCtD
Tinidazole—Abdominal pain—Etoposide—urinary bladder cancer	0.000869	0.00125	CcSEcCtD
Tinidazole—Body temperature increased—Etoposide—urinary bladder cancer	0.000869	0.00125	CcSEcCtD
Tinidazole—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000869	0.00125	CcSEcCtD
Tinidazole—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000867	0.00125	CcSEcCtD
Tinidazole—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000863	0.00124	CcSEcCtD
Tinidazole—Asthenia—Cisplatin—urinary bladder cancer	0.000861	0.00124	CcSEcCtD
Tinidazole—Pharyngitis—Epirubicin—urinary bladder cancer	0.000861	0.00124	CcSEcCtD
Tinidazole—Sweating—Doxorubicin—urinary bladder cancer	0.000857	0.00123	CcSEcCtD
Tinidazole—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000857	0.00123	CcSEcCtD
Tinidazole—Urethral disorder—Epirubicin—urinary bladder cancer	0.000851	0.00122	CcSEcCtD
Tinidazole—Angiopathy—Methotrexate—urinary bladder cancer	0.000841	0.00121	CcSEcCtD
Tinidazole—Immune system disorder—Methotrexate—urinary bladder cancer	0.000838	0.00121	CcSEcCtD
Tinidazole—Dizziness—Fluorouracil—urinary bladder cancer	0.000837	0.00121	CcSEcCtD
Tinidazole—Diarrhoea—Cisplatin—urinary bladder cancer	0.000821	0.00118	CcSEcCtD
Tinidazole—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000821	0.00118	CcSEcCtD
Tinidazole—Vomiting—Gemcitabine—urinary bladder cancer	0.000819	0.00118	CcSEcCtD
Tinidazole—Rash—Gemcitabine—urinary bladder cancer	0.000812	0.00117	CcSEcCtD
Tinidazole—Dermatitis—Gemcitabine—urinary bladder cancer	0.000811	0.00117	CcSEcCtD
Tinidazole—Hypersensitivity—Etoposide—urinary bladder cancer	0.00081	0.00117	CcSEcCtD
Tinidazole—Malnutrition—Methotrexate—urinary bladder cancer	0.000807	0.00116	CcSEcCtD
Tinidazole—Headache—Gemcitabine—urinary bladder cancer	0.000807	0.00116	CcSEcCtD
Tinidazole—Flushing—Epirubicin—urinary bladder cancer	0.000805	0.00116	CcSEcCtD
Tinidazole—Vomiting—Fluorouracil—urinary bladder cancer	0.000805	0.00116	CcSEcCtD
Tinidazole—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000799	0.00115	CcSEcCtD
Tinidazole—Rash—Fluorouracil—urinary bladder cancer	0.000799	0.00115	CcSEcCtD
Tinidazole—Dermatitis—Fluorouracil—urinary bladder cancer	0.000798	0.00115	CcSEcCtD
Tinidazole—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000797	0.00115	CcSEcCtD
Tinidazole—Headache—Fluorouracil—urinary bladder cancer	0.000793	0.00114	CcSEcCtD
Tinidazole—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000793	0.00114	CcSEcCtD
Tinidazole—Dysgeusia—Methotrexate—urinary bladder cancer	0.00079	0.00114	CcSEcCtD
Tinidazole—Asthenia—Etoposide—urinary bladder cancer	0.000789	0.00114	CcSEcCtD
Tinidazole—Angiopathy—Epirubicin—urinary bladder cancer	0.000787	0.00113	CcSEcCtD
Tinidazole—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000787	0.00113	CcSEcCtD
Tinidazole—Immune system disorder—Epirubicin—urinary bladder cancer	0.000784	0.00113	CcSEcCtD
Tinidazole—Pruritus—Etoposide—urinary bladder cancer	0.000778	0.00112	CcSEcCtD
Tinidazole—Nausea—Gemcitabine—urinary bladder cancer	0.000765	0.0011	CcSEcCtD
Tinidazole—Vomiting—Cisplatin—urinary bladder cancer	0.000763	0.0011	CcSEcCtD
Tinidazole—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000759	0.00109	CcSEcCtD
Tinidazole—Rash—Cisplatin—urinary bladder cancer	0.000757	0.00109	CcSEcCtD
Tinidazole—Dermatitis—Cisplatin—urinary bladder cancer	0.000756	0.00109	CcSEcCtD
Tinidazole—Malnutrition—Epirubicin—urinary bladder cancer	0.000755	0.00109	CcSEcCtD
Tinidazole—Diarrhoea—Etoposide—urinary bladder cancer	0.000753	0.00108	CcSEcCtD
Tinidazole—Nausea—Fluorouracil—urinary bladder cancer	0.000752	0.00108	CcSEcCtD
Tinidazole—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000749	0.00108	CcSEcCtD
Tinidazole—Flushing—Doxorubicin—urinary bladder cancer	0.000745	0.00107	CcSEcCtD
Tinidazole—Flatulence—Epirubicin—urinary bladder cancer	0.000744	0.00107	CcSEcCtD
Tinidazole—Dysgeusia—Epirubicin—urinary bladder cancer	0.00074	0.00106	CcSEcCtD
Tinidazole—Angiopathy—Doxorubicin—urinary bladder cancer	0.000729	0.00105	CcSEcCtD
Tinidazole—Malaise—Methotrexate—urinary bladder cancer	0.000728	0.00105	CcSEcCtD
Tinidazole—Dizziness—Etoposide—urinary bladder cancer	0.000727	0.00105	CcSEcCtD
Tinidazole—Muscle spasms—Epirubicin—urinary bladder cancer	0.000726	0.00105	CcSEcCtD
Tinidazole—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000725	0.00104	CcSEcCtD
Tinidazole—Vertigo—Methotrexate—urinary bladder cancer	0.000725	0.00104	CcSEcCtD
Tinidazole—Leukopenia—Methotrexate—urinary bladder cancer	0.000723	0.00104	CcSEcCtD
Tinidazole—Nausea—Cisplatin—urinary bladder cancer	0.000713	0.00103	CcSEcCtD
Tinidazole—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000701	0.00101	CcSEcCtD
Tinidazole—Convulsion—Methotrexate—urinary bladder cancer	0.000699	0.00101	CcSEcCtD
Tinidazole—Vomiting—Etoposide—urinary bladder cancer	0.000699	0.00101	CcSEcCtD
Tinidazole—Malnutrition—Doxorubicin—urinary bladder cancer	0.000699	0.00101	CcSEcCtD
Tinidazole—Rash—Etoposide—urinary bladder cancer	0.000693	0.000998	CcSEcCtD
Tinidazole—Dermatitis—Etoposide—urinary bladder cancer	0.000693	0.000997	CcSEcCtD
Tinidazole—Headache—Etoposide—urinary bladder cancer	0.000689	0.000992	CcSEcCtD
Tinidazole—Flatulence—Doxorubicin—urinary bladder cancer	0.000689	0.000991	CcSEcCtD
Tinidazole—Myalgia—Methotrexate—urinary bladder cancer	0.000687	0.000989	CcSEcCtD
Tinidazole—Arthralgia—Methotrexate—urinary bladder cancer	0.000687	0.000989	CcSEcCtD
Tinidazole—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000684	0.000985	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000683	0.000982	CcSEcCtD
Tinidazole—Malaise—Epirubicin—urinary bladder cancer	0.000681	0.00098	CcSEcCtD
Tinidazole—Discomfort—Methotrexate—urinary bladder cancer	0.000679	0.000977	CcSEcCtD
Tinidazole—Vertigo—Epirubicin—urinary bladder cancer	0.000679	0.000977	CcSEcCtD
Tinidazole—Leukopenia—Epirubicin—urinary bladder cancer	0.000676	0.000973	CcSEcCtD
Tinidazole—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000672	0.000967	CcSEcCtD
Tinidazole—Palpitations—Epirubicin—urinary bladder cancer	0.000668	0.000961	CcSEcCtD
Tinidazole—Confusional state—Methotrexate—urinary bladder cancer	0.000664	0.000956	CcSEcCtD
Tinidazole—Convulsion—Epirubicin—urinary bladder cancer	0.000655	0.000942	CcSEcCtD
Tinidazole—Nausea—Etoposide—urinary bladder cancer	0.000653	0.00094	CcSEcCtD
Tinidazole—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000649	0.000933	CcSEcCtD
Tinidazole—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000646	0.00093	CcSEcCtD
Tinidazole—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000645	0.000928	CcSEcCtD
Tinidazole—Myalgia—Epirubicin—urinary bladder cancer	0.000643	0.000926	CcSEcCtD
Tinidazole—Arthralgia—Epirubicin—urinary bladder cancer	0.000643	0.000926	CcSEcCtD
Tinidazole—Skin disorder—Methotrexate—urinary bladder cancer	0.00064	0.000921	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000639	0.000919	CcSEcCtD
Tinidazole—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000637	0.000917	CcSEcCtD
Tinidazole—Discomfort—Epirubicin—urinary bladder cancer	0.000635	0.000914	CcSEcCtD
Tinidazole—Malaise—Doxorubicin—urinary bladder cancer	0.00063	0.000907	CcSEcCtD
Tinidazole—Vertigo—Doxorubicin—urinary bladder cancer	0.000628	0.000904	CcSEcCtD
Tinidazole—Anorexia—Methotrexate—urinary bladder cancer	0.000628	0.000904	CcSEcCtD
Tinidazole—Leukopenia—Doxorubicin—urinary bladder cancer	0.000626	0.0009	CcSEcCtD
Tinidazole—Confusional state—Epirubicin—urinary bladder cancer	0.000622	0.000895	CcSEcCtD
Tinidazole—Palpitations—Doxorubicin—urinary bladder cancer	0.000618	0.000889	CcSEcCtD
Tinidazole—Convulsion—Doxorubicin—urinary bladder cancer	0.000606	0.000872	CcSEcCtD
Tinidazole—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000605	0.00087	CcSEcCtD
Tinidazole—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000604	0.000869	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.0006	0.000864	CcSEcCtD
Tinidazole—Skin disorder—Epirubicin—urinary bladder cancer	0.000599	0.000862	CcSEcCtD
Tinidazole—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000596	0.000858	CcSEcCtD
Tinidazole—Insomnia—Methotrexate—urinary bladder cancer	0.000596	0.000857	CcSEcCtD
Tinidazole—Arthralgia—Doxorubicin—urinary bladder cancer	0.000595	0.000856	CcSEcCtD
Tinidazole—Myalgia—Doxorubicin—urinary bladder cancer	0.000595	0.000856	CcSEcCtD
Tinidazole—Paraesthesia—Methotrexate—urinary bladder cancer	0.000592	0.000851	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000591	0.00085	CcSEcCtD
Tinidazole—Discomfort—Doxorubicin—urinary bladder cancer	0.000588	0.000846	CcSEcCtD
Tinidazole—Anorexia—Epirubicin—urinary bladder cancer	0.000588	0.000846	CcSEcCtD
Tinidazole—Dyspnoea—Methotrexate—urinary bladder cancer	0.000587	0.000845	CcSEcCtD
Tinidazole—Somnolence—Methotrexate—urinary bladder cancer	0.000586	0.000843	CcSEcCtD
Tinidazole—Dyspepsia—Methotrexate—urinary bladder cancer	0.00058	0.000835	CcSEcCtD
Tinidazole—Confusional state—Doxorubicin—urinary bladder cancer	0.000575	0.000828	CcSEcCtD
Tinidazole—Decreased appetite—Methotrexate—urinary bladder cancer	0.000573	0.000824	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000569	0.000818	CcSEcCtD
Tinidazole—Fatigue—Methotrexate—urinary bladder cancer	0.000568	0.000817	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000562	0.000808	CcSEcCtD
Tinidazole—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000559	0.000805	CcSEcCtD
Tinidazole—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000559	0.000804	CcSEcCtD
Tinidazole—Insomnia—Epirubicin—urinary bladder cancer	0.000558	0.000802	CcSEcCtD
Tinidazole—Skin disorder—Doxorubicin—urinary bladder cancer	0.000554	0.000797	CcSEcCtD
Tinidazole—Paraesthesia—Epirubicin—urinary bladder cancer	0.000554	0.000797	CcSEcCtD
Tinidazole—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000551	0.000794	CcSEcCtD
Tinidazole—Dyspnoea—Epirubicin—urinary bladder cancer	0.00055	0.000791	CcSEcCtD
Tinidazole—Somnolence—Epirubicin—urinary bladder cancer	0.000548	0.000789	CcSEcCtD
Tinidazole—Anorexia—Doxorubicin—urinary bladder cancer	0.000544	0.000783	CcSEcCtD
Tinidazole—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000543	0.000781	CcSEcCtD
Tinidazole—Dyspepsia—Epirubicin—urinary bladder cancer	0.000543	0.000781	CcSEcCtD
Tinidazole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000539	0.000775	CcSEcCtD
Tinidazole—Decreased appetite—Epirubicin—urinary bladder cancer	0.000536	0.000771	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000532	0.000766	CcSEcCtD
Tinidazole—Fatigue—Epirubicin—urinary bladder cancer	0.000532	0.000765	CcSEcCtD
Tinidazole—Constipation—Epirubicin—urinary bladder cancer	0.000527	0.000759	CcSEcCtD
Tinidazole—Urticaria—Methotrexate—urinary bladder cancer	0.000523	0.000753	CcSEcCtD
Tinidazole—Body temperature increased—Methotrexate—urinary bladder cancer	0.000521	0.000749	CcSEcCtD
Tinidazole—Abdominal pain—Methotrexate—urinary bladder cancer	0.000521	0.000749	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00052	0.000748	CcSEcCtD
Tinidazole—Insomnia—Doxorubicin—urinary bladder cancer	0.000516	0.000742	CcSEcCtD
Tinidazole—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000512	0.000737	CcSEcCtD
Tinidazole—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000509	0.000732	CcSEcCtD
Tinidazole—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000508	0.000731	CcSEcCtD
Tinidazole—Somnolence—Doxorubicin—urinary bladder cancer	0.000507	0.00073	CcSEcCtD
Tinidazole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000504	0.000725	CcSEcCtD
Tinidazole—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000502	0.000723	CcSEcCtD
Tinidazole—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000496	0.000714	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000493	0.000709	CcSEcCtD
Tinidazole—Fatigue—Doxorubicin—urinary bladder cancer	0.000492	0.000708	CcSEcCtD
Tinidazole—Urticaria—Epirubicin—urinary bladder cancer	0.00049	0.000705	CcSEcCtD
Tinidazole—Constipation—Doxorubicin—urinary bladder cancer	0.000488	0.000702	CcSEcCtD
Tinidazole—Abdominal pain—Epirubicin—urinary bladder cancer	0.000487	0.000701	CcSEcCtD
Tinidazole—Body temperature increased—Epirubicin—urinary bladder cancer	0.000487	0.000701	CcSEcCtD
Tinidazole—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000485	0.000698	CcSEcCtD
Tinidazole—Asthenia—Methotrexate—urinary bladder cancer	0.000473	0.00068	CcSEcCtD
Tinidazole—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00047	0.000676	CcSEcCtD
Tinidazole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000466	0.000671	CcSEcCtD
Tinidazole—Pruritus—Methotrexate—urinary bladder cancer	0.000466	0.000671	CcSEcCtD
Tinidazole—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000454	0.000654	CcSEcCtD
Tinidazole—Urticaria—Doxorubicin—urinary bladder cancer	0.000453	0.000652	CcSEcCtD
Tinidazole—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000451	0.000649	CcSEcCtD
Tinidazole—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000451	0.000649	CcSEcCtD
Tinidazole—Diarrhoea—Methotrexate—urinary bladder cancer	0.000451	0.000649	CcSEcCtD
Tinidazole—Asthenia—Epirubicin—urinary bladder cancer	0.000442	0.000637	CcSEcCtD
Tinidazole—Pruritus—Epirubicin—urinary bladder cancer	0.000436	0.000628	CcSEcCtD
Tinidazole—Dizziness—Methotrexate—urinary bladder cancer	0.000436	0.000627	CcSEcCtD
Tinidazole—Diarrhoea—Epirubicin—urinary bladder cancer	0.000422	0.000607	CcSEcCtD
Tinidazole—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00042	0.000605	CcSEcCtD
Tinidazole—Vomiting—Methotrexate—urinary bladder cancer	0.000419	0.000603	CcSEcCtD
Tinidazole—Rash—Methotrexate—urinary bladder cancer	0.000415	0.000598	CcSEcCtD
Tinidazole—Dermatitis—Methotrexate—urinary bladder cancer	0.000415	0.000597	CcSEcCtD
Tinidazole—Headache—Methotrexate—urinary bladder cancer	0.000413	0.000594	CcSEcCtD
Tinidazole—Asthenia—Doxorubicin—urinary bladder cancer	0.000409	0.000589	CcSEcCtD
Tinidazole—Dizziness—Epirubicin—urinary bladder cancer	0.000408	0.000587	CcSEcCtD
Tinidazole—Pruritus—Doxorubicin—urinary bladder cancer	0.000404	0.000581	CcSEcCtD
Tinidazole—Vomiting—Epirubicin—urinary bladder cancer	0.000392	0.000564	CcSEcCtD
Tinidazole—Nausea—Methotrexate—urinary bladder cancer	0.000391	0.000563	CcSEcCtD
Tinidazole—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00039	0.000562	CcSEcCtD
Tinidazole—Rash—Epirubicin—urinary bladder cancer	0.000389	0.000559	CcSEcCtD
Tinidazole—Dermatitis—Epirubicin—urinary bladder cancer	0.000388	0.000559	CcSEcCtD
Tinidazole—Headache—Epirubicin—urinary bladder cancer	0.000386	0.000556	CcSEcCtD
Tinidazole—Dizziness—Doxorubicin—urinary bladder cancer	0.000377	0.000543	CcSEcCtD
Tinidazole—Nausea—Epirubicin—urinary bladder cancer	0.000366	0.000527	CcSEcCtD
Tinidazole—Vomiting—Doxorubicin—urinary bladder cancer	0.000363	0.000522	CcSEcCtD
Tinidazole—Rash—Doxorubicin—urinary bladder cancer	0.00036	0.000518	CcSEcCtD
Tinidazole—Dermatitis—Doxorubicin—urinary bladder cancer	0.000359	0.000517	CcSEcCtD
Tinidazole—Headache—Doxorubicin—urinary bladder cancer	0.000357	0.000514	CcSEcCtD
Tinidazole—Nausea—Doxorubicin—urinary bladder cancer	0.000339	0.000488	CcSEcCtD
